Dendrite Clinical Systems and the Society for Cardiothoracic Surgery in the UK are pleased to announce the SCTS Conference News 2022 newspaper is now available to view/download. The newspaper reports a multitude of presentations from the meeting including the latest and the best information on new technologies and techniques in cardio-thoracic surgery.
Researchers led by the Clinical Research Unit at the Special Unit for Biomedical Research and Education (SUBRE), Aristotle University of Thessaloniki School of Medicine, Greece, have initiated a randomised control trial (RCT) that will compare minimally invasive extracorporeal circulation (MiECC) with conventional cardiopulmonary bypass (cCPB).
Dendrite Clinical Systems, working in close cooperation with the SCTS and several cardiac centres, has developed a series of ‘Dashboards’ that allow users to access to their unit’s surgical outcomes and compare them to national results in real-time. By uploading their data to the central Dendrite National Cardiac Surgical Registry, individual units or centres can instantly benchmark their results via an on-line database for internal consumption to assist units with their own clinical governance and for auditing purposes.
Dendrite Clinical Systems is delighted to announce the first ever report from New Zealand’s Te Rēhita Mate Ūtaetae - Breast Cancer Foundation National Register. The ground-breaking report, titled, “30,000 voices: Informing a better future for breast cancer in New Zealand,” covers 30,000 patients diagnosed from 2003 to 2019.
The European Society for Organ Transplantation (ESOT) has signed an agreement to develop a series of web-based registries on organ 
Dendrite Clinical Systems and The American Vein and Lymphatic Society (formerly the American College of Phlebology) are delighted to announce the launch of the American Vein and Lymphatic Society Registry - a ‘real-time’ clinical database that will identify practice patterns for venous and lymphatic disease diagnosis and treatment across North America.
The aim of the registry is to analyse the aggregate data and produce an annual publication that will outline important demographic features, risk factors, diagnostic characteristics, disease patterns, and treatment outcomes of venous and lymphatic disease within North America.
It is hoped that the Registry will assist the AVLS in developing standards of care and guideline documents for the treatment of various venous and lymphatic disease by improving the standards of medical practitioners, the quality of patient care and patient management.
The Registry will allow physicians to enter the demographics, risk factors, clinical features, management details and follow-up of all major venous and lymphatic diseases. Outcome reports (e.g. risk-factor distribution, indications, patency rates, and complication rates) will be available in real time and physicians will have the ability to compare them with the aggregated outcomes of all entries in the database. The Registry can be programmed to generate lists for pending follow-ups, letters to patients, and reminder emails to physicians.
The Registry is web-based and allows the individual clinician to enter patient information into the database from the hospital, an office-based practice, or even from home. Clinicians can add as many cases as they wish and where possible they will be encouraged to put on retrospective data (if available).
“We are thrilled to be part of this exciting project. The registry is the largest database of its kind specifically designed for venous and lymphatic disease and will be of tremendous educational value to the AVLS, its members and ultimately, patients,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “The Registry represents an important milestone for the company and reflects our expanding database portfolio.”
